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ABSTRACT:  
 
SOX transcription factors have the capacity to modulate stem/progenitor cell proliferation and 
differentiation in a dose-dependent manner. SOX9 is expressed in the small intestine epithelial stem cell 
zone. Therefore, we hypothesized that differential levels of SOX9 may exist, influencing proliferation 
and/or differentiation of the small intestine epithelium. Sox9 expression levels in the small intestine were 
investigated using a Sox9EGFP transgenic mouse. Sox9EGFP levels correlate with endogenous SOX9 
levels, which are expressed at two steady-state levels, termed Sox9EGFPLO and Sox9EGFPHI. Crypt-based 
columnar cells are Sox9EGFPLO and demonstrate enriched expression of the stem cell marker, Lgr5. 
Sox9EGFPHI-cells express Chromogranin-A and Substance-P but do not express Ki67 and Neurogenin3, 
indicating Sox9EGFPHI-cells are post-mitotic enteroendocrine cells. Over-expression of SOX9 in a crypt 
cell line stopped proliferation and induced morphologic changes. These data support a bimodal role for 
SOX9 in the intestinal epithelium where low SOX9-expression supports proliferative capacity, while 
high SOX9-expression suppresses proliferation. 
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INTRODUCTION: 
 
 Complete renewal of the adult mammalian small intestinal epithelium occurs every 3 to 14 days 
and is driven by multi-potential stem cells located in the base of the crypts (4, 11). The impressive rate 
of tissue turnover requires well-coordinated maintenance of the stem cell pool and also the appropriate 
differentiation of the transit amplifying progenitors into the four mature post-mitotic lineages of the 
small intestine (7-11). While most progenitors differentiate into absorptive cells, a small minority of 
progenitors differentiates into the remaining three secretory cell types: goblet cells, enteroendocrine 
cells, and Paneth cells. 
 The multipotent stem cells and committed progenitor cells that give rise to the post-mitotic 
intestinal epithelium have been difficult to study due to the lack of specific biomarkers, animal models, 
and methods to isolate live stem/progenitor cell populations for gene expression analysis. The specific 
location of the small intestine epithelial stem cell has been thought for many years to be located at cell 
position +4 (as numbered from the bottom of the crypt up the crypt-villus axis) (4). This putative stem 
cell location was based on a slow cell division criterion of the cells at an average position of +4 using 
3H-Thymidine and BrdU label retention assays, which do not assess the multipotency and self-renewal 
characteristics of a stem cell.  
Recently, an elegant in vivo lineage tracing experiment, using Lgr5 as a biomarker, demonstrated 
that a population of multipotential intestinal epithelial stem cells localize to the very base of the crypt 
(cell positions 0, 1’, 2’, 4; as defined by (2) and have been previously characterized as crypt-based 
columnar cells (CBCs) (4, 9, 11). More recently, lineage tracing has demonstrated that the polycomb 
group gene, Bmi1, which is expressed primarily in a pool of cells around the +4 region also has 
multipotent capacity but only in the proximal small intestine (36). Although it is not clear whether the 
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Lgr5+ and Bmi1+ cells are functionally equivalent, it has been hypothesized that one population may be 
a slower dividing ‘quiescent’ stem cell (cells at position +4) which gives rise to more rapidly dividing 
multipotent stem cells (the CBCs) (24, 34).  
Nonetheless, both cell types are under the influence of intrinsic and extrinsic signals directing the 
decisions to self-renew and differentiate into all post-mitotic cell types of the small intestine epithelium. 
The intrinsic and extrinsic genetic pathways controlling the defining properties of stem cells, self-
renewal capacity and multipotency, are not fully understood in the intestine. Perhaps the most well 
studied pathways critical to the development and maintenance of the intestinal epithelium include the 
Wnt/ß-catenin and Notch pathways. When Wnt-signaling is engaged, a cascade of events leads to nuclear 
localization of ß-catenin and transcriptional enhancement of target genes involved in supporting 
proliferation (i.e., c-myc, cyclin-D1). Genetic ablation of Wnt-signaling components results in crypt loss 
and the eventual disruption of intestinal epithelium homeostasis (23, 31).  
Studies describing perturbations in normal Notch1-receptor signaling (by gain or loss of 
function) have likewise demonstrated the critical role of the Notch pathway in intestinal epithelial 
development, specifically in controlling the cell fate decisions of intestinal stem/progenitor cells (39, 
46). When the Notch1-pathway is activated, its downstream target gene, Hes1, represses Math1 
expression and promotes an absorptive cell fate over a secretory lineage fate. Negative disruption of the 
Notch1-pathway, either pharmacologically (41) or genetically, results in an aberrant increase in the 
numbers of secretory-cell lineages. Collectively, these studies indicate that precise control of the Wnt- 
and Notch1- pathways by modulating factors is critical for normal proliferation and differentiation of 
intestinal stem/progenitor cells. 
A common feature of both the Wnt and Notch pathways is that they appear to be modulated by 
Sox (Sry-Box) genes (1, 3, 40), indicating a critical role for Sox-transcription factors in normal intestinal 
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epithelium homeostasis. Sox genes are a family of at least 20 closely related transcription factors, which 
are defined by the presence of a HMG (High Mobility Group) domain (28). All Sox-factors bind a 
relatively loose consensus sequence, (A/T)(A/T)CAA(A/T)G (28), resulting in dramatic DNA bending 
(37, 44) that has been hypothesized to be critical for bringing distal control elements to proximal 
transcriptional start sites (44). SOX-factor competition for a single cis-control element combined with 
the physical interaction of SOX-factors with other transcription factors (45) influences the specificity of 
target gene transcription (21). The ability of SOX factors to bind the same consensus sequence has been 
linked to highly redundant function in some cell types (14, 19, 27) and has obscured understanding the 
specific role of some SOX genes using gene-targeting technologies. The notion that multiple SOX-
factors with differential capacities to modulate transcription are able to compete for transcriptional 
control of the same target gene points to the concept of how differential levels of SOX-factors in a single 
cell might influence proliferation or the outcome of lineage specification.  
An interesting feature of SOX-factors is that they can function as dose-dependent regulators of 
stem/progenitor cell potency and competence (33, 40). Disruption in the proper balance of SOX-factor 
levels can result in severe congenital defects. Several conditions in humans and mice are caused by 
subtle changes in regulation or haplo-insufficiency of some Sox genes. For example, distinct 
hypomorphic levels of Sox2 result in esophageal atresia and tracheoesophageal fistula (33), and a range 
of eye phenotypes from anophthalmia to microphthalmia (15, 40). Likewise, the loss of a single Sox9 
allele presents clinically as sex-reversal with Campomelic Dysplasia (22, 42). In both cases of SOX-
factor deficiency, aberrant maintenance and differentiation of the stem/progenitor cell pool is causative 
to the clinical sequelae. Taken together, these reports indicate that discrete levels of SOX-factors play a 
critical role in normal differentiation of stem/progenitor cell populations. 
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RT-PCR analysis demonstrates that Sox3, 4, 5, 7, 9, 10, 17 and 18 mRNAs are expressed in 
whole intestine preparations (5). Of these Sox-factors, Sox9 has been the most widely studied in the 
intestine. Expression of SOX9 protein has been localized to the stem cell and transit amplifying zones of 
the crypt (5). Interestingly, sporadic SOX9-expressing cells have also been reported to be located 
throughout the non-proliferating villus epithelium (3, 5, 26).  
Because distinct levels of SOX-factors appear to be critical for proper proliferation and 
differentiation in stem cell biology, we hypothesized that differential SOX9 expression may be playing a 
similar role in stem/progenitor cell populations in the intestine. To explore this possibility we utilized a 
BAC transgenic SOX9EGFP animal model where EGFP is expressed by the regulatory regions of Sox9. In 
this study we examine both the Sox9 transcriptional activity (via EGFP expression) and endogenous 
levels of SOX9 protein throughout the crypt/villus axis of the small intestine. Additionally, we 
investigate the molecular characteristics and cellular identities of Sox9-expressing stem/progenitor cells 
and post-mitotic populations, and test whether increasing the levels of SOX9 is able to confer 
phenotypic changes in a non-transformed intestinal epithelial crypt cell line. The results of this study 
provide further insight into a function for Sox9 in both the stem/progenitor cell populations, and in a 
subset of post-mitotic cells in the crypts and villi.  
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MATERIALS AND METHODS: 
 
Mice/Genotyping 
 The Sox9EGFP mouse line was originally generated as part of the GENSAT Brain Atlas Project 
(17) and contains genomic integration of a modified BAC (RP32-140D18) with ~75.5 kb upstream and 
~151kb downstream sequence to Sox9. Frozen Sox9EGFP mouse embryos were obtained from the Mutant 
Mouse Regional Resource Center (University of California-Davis) and reconstituted by transfer into 
foster mice. All mice are on the outbred CD-1 strain and were maintained as heterozygotes on the CD-1 
genetic background. Mice breed normally and live to adulthood with no overt phenotypes due to the 
transgene. At ~12 days post-natal, tail snips were viewed under an epi-fluorescent microscope fitted 
with filters for EGFP visualization. A high level of EGFP fluorescence compared to transgene negative 
control mice was scored as a positive for the Sox9EGFP transgene.  
 
Immunostaining/Microscopy: 
 For tissue preparation, small intestines were dissected from adult Sox9EGFP mice (>8 weeks of 
age) and luminal contents were flushed-out with PBS followed immediately by a single flush with 
freshly made 4% paraformaldehyde (PFA). The intestine was opened along the duodenal-ileal axis, 
placed on filter paper, and fixed for an additional 14-18 hours at 4°C. The tissues were then prepared for 
cryosectioning by immersion in 30% sucrose solution for at least 24 hours at 4°C. Tissues were then 
embedded in Optimal Cutting Temperature (OCT) medium and frozen on dry ice. The OCT blocks were 
stored at -80°C until cryosectioning. Thin sections (8-10µm) were cut on a cryostat and placed on 
positively charged microscope slides for staining and microscopy. This tissue preparation technique is 
critical for preserving the EGFP fluorescence.  
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 For immunostaining, the sections were washed twice in PBS to remove OCT, followed by 
incubation in blocking medium (5% normal goat serum (NGS), in PBS-0.3% Triton-X100) for at least 
30 minutes at room temperature (21-25°C). Primary antibodies were applied to the tissue sections in 
antibody staining solution (1% NGS, in PBS-0.3% Triton-X100). Dilutions were as follows: αEGFP 
(chicken, 1:500, Aves Labs, Inc. GFP-1020), αSOX9 (rabbit, 1:1000, Chemicon, Temecula, CA, 
AB5535), αNGN3 (rabbit, 1:250, Chemicon, AB5684), αSubstance-P (rat; 1:500, Chemicon, 
MAB356), αChromogranin-A (rabbit, 1:500, Immunostar, 20086), αKi67 (mouse, 1:100, Dako, 
Carpinteria, CA M7249), αLysozyme (rabbit, 1:1000, Diagnostics Biosystems, Pleasanton, CA, RP 
028). All secondary antibodies (αRabbit-Cy3, Sigma, Saint Louis, MO, C2306; αRabbit-Alexafluor 
488, Molecular Probes, Eugene, OR, Z-25302; αRat-Alexafluor 555, Molecular Probes, Z-25305) were 
used at a 1:500 dilution in staining buffer. For Ki67 it was necessary to amplify the signal using αMouse 
IgG-Biotinylated (1:200, Jackson Immunoresearch Labs, West Grove, PA) followed by AlexFluor-555 
labeled streptavidin (1:250, Molecular Probes, S32355). Antigen retrieval using Reveal Buffer (Biocare 
Medical, Concord, CA, RV1000L2J) was required for NGN3, Ki67, and Chromogranin A. Nuclei were 
stained with Draq5 (1:10,000, Biostatus, Ltd, San Diego, CA, BOS-889-001). Background staining was 
negligible as determined by non-specific IgG staining. Unless otherwise noted, co-staining/positive 
staining statistics were generated from cells from at least 50 crypts/villi. 
 For whole mount staining of crypts, whole crypts were isolated as described in the ‘Epithelium 
Dissociation’ section of the methods without the Dispase treatment. Approximately, 500 crypts were 
fixed in 4% PFA at 4°C for ~18 hours, then washed 5 times with PBS. For all wash procedures, crypts 
were gently mixed and allowed to settle to the bottom of tube (and not centrifuged). Washes and staining 
buffers were removed from crypts by gentle suction. Crypts were blocked in 500 µl of 5% NGS/PBS-T 
for 1 hour at room temperature. Primary antibodies were added to 500 µl of staining buffer and allowed 
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to incubate for ~18 hours at 4°C. The crypts were then washed 5 times with 1.5 mls PBS-T/wash. 
Secondary antibodies (already described) were added 1:500 in 1% NGS/PBS-T and incubated at room 
temperature for at least 2 hours. The secondary antibodies were removed and the crypts were washed 5 
times with PBS-T for 30 minutes each. For co-staining with αLysozyme and αSOX9 it was necessary to 
label the Lysozyme antibody with Alexafluor 488 using the Zenon primary antibody labeling kit 
(Invitrogen). Staining for SOX9 was conducted first followed by staining for Lysozyme. Nuclei were 
stained with Draq5. 
 Epifluorescent images were captured on an Olympus IX70 fitted with an Olympus digital 
camera. Objective lenses used were 20X and 40x with numerical apertures of 0.55 and 1.40 respectively. 
All confocal images represent 1.5 µm optical sections unless otherwise noted and crypts were captured 
using confocal optical Z-sectioning (1.0 µm optical sections) and compiled using Zeiss LSM Image 
Software (Zeiss, Thornwood, NY). Objective lenses for the confocal images were 40X with a numerical 
aperture = 0.1.  
 
Immunoblotting 
 Whole cell lysates were made from virus infected IEC-18 cells by adding RIPA buffer (0.15 M 
NaCl, 50 mM Tris-Cl, pH-7.2, 1% deoxycholic acid, 1% Triton-X 100, 0.1% SDS) and 1X protease 
inhibitors (Sigma, P8340) to two 15 cm plates. Prior to cell lysis, virus infected cells had been selected 
for stable transgene integration using puromycin selection for 10-days. Whole cell lysates were 
separated on a 10% SDS-PAGE gel and proteins were transferred to PVDF membrane (Hybond LFP; 
GE Healthcare, Piscataway, NJ). The membranes were probed with anti-c-MYC (SC-40; Santa Cruz 
Biotech), anti-PCNA (MAB424R; Chemicon), and anti-ß-actin (A5316; Sigma), blocking in BLOTTO 
(5% dried milk in Tris-buffered Saline-Tween, 0.75%; TBS-T) for 30 minutes followed by incubation 
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with primary antibodies diluted in BLOTTO. Primary antibodies were detected with anti-IgG-
Horseradish peroxidase conjugated secondary antibodies diluted in BLOTTO. The membranes were 
then incubated in the HRP detection agent (ECL, GE Healthcare) for five minutes and then exposed to 
film. Films were scanned on a flatbed film scanner to generate digital images. 
 
Epithelium Dissociation/FACS: 
To isolate intestinal crypt cells for Fluorescence Activated Cell Sorting (FACS), small intestine 
epithelium was dissociated into single cells essentially as previously described (13) with slight 
modifications. For FACS experiments mouse intestine were flushed with cold phosphate-buffered saline 
(PBS), cut open lengthwise in approximately 10 cm long pieces, and immersed in PBS/30 mM 
ethylenediaminetetraacetic acid (EDTA)/1.5 mM dithiothreitol (DTT) over ice for 20 minutes. The 
solution was disposed of and the tissue was shaken vigorously in fresh PBS/30 mM EDTA for 
approximately 30 seconds before being incubated at 37°C for 10 minutes. Intact tissue was discarded 
and dissociated crypts and villi were pelleted at 2500 rpm for 5 minutes. The cells were washed twice 
with cold PBS, resuspended in Hank’s buffered saline solution (HBSS)/0.3U/mL dispase at 37°C and 
shaken approximately every 2 minutes for 10 minutes. Then, fetal bovine serum (FBS, 5%) and 100 µg 
DNaseI was added before the cells were passed through a 70 µm filter. Cells were pelleted at 2500 rpm 
for 5 minutes and resuspended in 4 mL HBSS with 5% FBS, then passed through a 100 µm filter and 
combined with an additional 100 µg DNaseI. Equivalent numbers of cells from three animals were 
combined prior to FACSorting. Sox9EGFPNEGATIVE, Sox9EGFPHI, and Sox9EGFPLO cells were isolated using a 
MoFlo FACS machine (Dako/Cytomation). Cells were collected in ice cold HBSS and kept on ice 
throughout the sort. Time between death of the mouse to RNA extraction was kept to 3.5 to 4 hours to 
ensure the highest quality of RNA.  
 11
 
cDNA Preparation/Real-time PCR Analysis: 
 cDNA from approximately 5 x 104 cells from each FACSorted population (Sox9EGFPNEGATIVE, 
Sox9EGFPHI , and Sox9EGFPLO) was made using RNAqueous Micro Kit (Ambion, Austin, TX) according 
to the manufacturer’s protocols. Real-time PCR was conducted for each sample in triplicate on 
approximately 1/20,000 of the total amount of cDNA generated. Taqman probes (Hes1, 
Mm00468601_m1; Notch1, Mm00435245_m1; Lgr5, Mm00438890_m1; Msi1, Mm00485224_m1; 
Sox9, Mm00448840_m1; 18S, HS99999901) for each gene were obtained from Applied Biosystems 
(Pleasanton, CA) and used in reactions according to the manufacture’s protocol. 18S ribosomal RNA 
was amplified and used as the internal control gene for sample comparison. Delta CT values were 
calculated to obtain fold-changes for sample comparison (30). 
 
Lentivirus Production/Cell Culture: 
The lentiviral vectors were constructed using the plasmid backbone, pLVX-Puro, from Clontech 
(Madison, WI). To generate the pLVX-SOX9-EGFP vector, the coding sequence for murine SOX9 was 
cloned into the polylinker of a shuttle vector just 5’ of an internal ribosomal entry site (IRES) linked to 
EGFP coding sequence. The SOX9-IRES-EGFP DNA fragment was then cloned into the pLVX-Puro 
vector. The control viral vector, pLVX-EGFP, contains all the elements of pLVX-SOX9-EGFP minus 
the SOX9 coding sequence. High titer lentivirus was generated according the Lenti-X system 
specifications (ClonTech).  
The IEC-18 cell line was cultured in medium according to previously established optimal conditions 
(18): high-glucose Dulbecco’s Modified Eagle Medium (DMEM-H), 10% Fetal Bovine Serum, 0.1% 
Zinc/Insulin (Gibco, Grand Island, NY), 10 U/ml penicillin/streptomycin and 2 mM L-glutamine. At 
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~80% cell confluence, the medium was replaced with the normal medium containing the lentivirus and 
polybrene at 4.0 μg/mL for overnight transduction. At 48 hr., approximately 75%-80% of the cells were 
infected as assessed by EGFP fluorescence. The transduction medium was replaced after 24 hours with 
the standard IEC-18 medium. After 48 hours the cells were puromycin-selected (at 2.0 μg/mL) in the 
standard IEC-18 culture medium. Selection continued for 10 days with cells analyzed daily for EGFP 
levels and morphology by microscopy. 
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RESULTS: 
 
Sox9EGFP is expressed primarily in the base of the crypt in non-Paneth cell populations 
 
 The Sox9EGFP mouse was originally generated as part of the GENSAT brain-mapping project and 
constructed by insertion of a bacterial artificial chromosome (BAC) into the mouse genome (17). The 
BAC containing the Sox9 locus was genetically modified to introduce the EGFP coding sequence just 5’ 
of the Sox9 transcriptional start site, thus destroying any transgenic expression of Sox9 from the BAC. 
The Sox9EGFP mice breed normally and do not have any deleterious phenotype resulting from EGFP 
transgene expression.  
Upon initial examination of the small intestine, we observed a restricted expression pattern of 
EGFP that localized exclusively to epithelial cells primarily at the base of the crypt in the Paneth cell 
zone (Figure 1A). As has been previously reported (5), we also observed sporadic Sox9EGFP positive 
cells in the villus (Figure 1B). This expression pattern of the Sox9EGFP transgene was observed 
throughout the duodenal-ileal axis. No Sox9EGFP expression was observed in the lamina propria, 
muscularis, bone marrow or circulating lymphocytes (as assessed by flow cytometry). 
Upon further examination of the crypts using brightfield microscopy, Sox9EGFP appeared to be 
mostly expressed in a cell population that was intercalated between the granulated Paneth cells and 
supra-Paneth cell location but not in Paneth cells themselves (Figure 1C). To rule out the possibility that 
a small sub-set of Sox9EGFP-expressing Paneth cells might have been overlooked in a thin cryostat 
section using Paneth cell morphology as an identifying criterion, we co-stained whole crypts for the 
Paneth cell marker, Lysozyme (6), and conducted three-dimensional (3-D) confocal microscopy. Three-
dimensional reconstruction of the entire crypt demonstrates that Sox9EGFP is expressed in all cells at the 
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base of the crypt except Paneth cells. (Figure 1D, Supplemental Figure S1).  Thus, a population of 
Sox9EGFP positive cells in the crypt base appears to be consistent with intercalating crypt-based columnar 
cells (CBCs). 
 
Sox9EGFP is expressed at two discrete levels 
 
 Consistent with our hypothesis, there are two distinct levels of Sox9EGFP expression, termed 
Sox9EGFPHI and Sox9EGFPLO, in the base of the crypt (Figure 2A). To establish whether endogenous 
SOX9 levels correlated with Sox9EGFP transgene levels, we stained Sox9EGFP small intestines for SOX9 
protein. One-micron confocal microscopy slices demonstrate a direct correlation between the graded 
levels of Sox9EGFP and endogenous SOX9. Empirical evidence suggested that the Sox9EGFP high cells 
were concentrated in a supra-Paneth cell region, a region traditionally accepted as part of the stem cell 
niche. To quantify this observation we counted the position of Sox9EGFPHI cells using the standard cell 
numbering scheme where cell position 1 is at the base of the crypt (Figure 2B). Additionally, we 
assessed the total number of Sox9EGFPHI cells from the crypt base to the villus junction in intact crypt 
preparations. The results indicate there are between 1 and 6 Sox9EGFPHI cells per crypt 
(mean=3.1;S.E.M=1.4) and that most Sox9EGFPHI cells localize to position +4-6 (average +5) (Figure 
2C). On the villus, all Sox9EGFP positive cells had a Sox9EGFPHI status and did not appear to be clustered 
in any particular region or pattern. 
 
Distinct SOX9 expression signatures define two populations of Paneth cells 
 
Several investigations have associated SOX9 immunostaining with granulated Paneth cells, 
however, Sox9 mRNA expression in Paneth cells has never been established (3, 5, 26). Although it 
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appears from these previous studies that SOX9 protein is expressed in some Paneth cells, it is unclear in 
the absence of a second genetic biomarker whether the nuclear staining is in the Paneth cells or the 
intercalating CBCs. In light of the absence of any Sox9EGFP expression in Lysozyme positive cells 
(Figure 1D), we indeed questioned whether there was SOX9 protein expression in the entire Lysozyme 
positive Paneth cell compartment. Using 3-D confocal imaging of intact crypts we demonstrate there are 
two populations of Paneth cells (defined as Lysozyme+SOX9+ or Lysozyme+SOX9-) existing in a 1:1 
ratio per crypt (Figure 2D, Supplemental Figure S2). Neither of these two populations appears to 
localize to a particular region of the base of the crypt (i.e., at the very base of the crypt or higher up the 
crypt axis). One possible interpretation for the lack of Sox9EGFP expression in the SOX9+ Paneth cells is 
that the cis-regulatory elements controlling Sox9 expression in Paneth cells are not present in the Sox9 
BAC clone used to generate the mice. 
 
Sox9EGFPLO cells demonstrate enhanced signaling for maintenance of ‘stemness’ 
  
 To better characterize the ‘stemness’, genetic and cellular differences between Sox9EGFPLO and 
Sox9EGFPHI cells, we investigated the expression of Notch1-pathway genes. Studies in stem/progenitor 
cells indicate that decreases in Notch1 receptor signaling lead to decreases in Hes1-repression of Math1, 
thus pushing stem/progenitor cell fate towards a secretory lineage (16, 38, 39, 46). To determine 
whether there was differential Notch1 expression and downstream signaling between Sox9EGFPHI and 
Sox9EGFPLO cells, we assessed the mRNA levels for Notch1 and its downstream target gene, Hes1, in 
these two cell populations. Small intestine epithelium was dissociated and the single cells were 
FACSorted based on either Sox9EGFPLO or Sox9EGFPHI expression status. Real-time semi-quantitative 
PCR was used to assess relative mRNA levels between the two samples (Figure 3A). The data show 
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there is a 5-fold enrichment of Sox9 mRNA in Sox9EGFPHI cells compared to Sox9EGFPLO cells validating 
the EGFP intensity-based cell sorting. The data also demonstrate there is a 10-fold enrichment of Notch1 
mRNA in Sox9EGFPLO cells with a concomitant 11-fold increase in Hes1, the downstream target of 
Notch-signaling (Figure 3B). These data indicate that the Notch1 pathway is activated to higher degree 
in Sox9EGFPLO cells suggesting secretory lineage fate is being suppressed and an uncommitted state 
and/or absorptive fate is being maintained in Sox9EGFPLO cells.  
 
Sox9EGFPLO cells demonstrate enriched levels of ‘stemness’ gene expression 
 
Two characteristics of Sox9EGFPLO cells suggest they in part comprise the multipotent stem cell 
population. These characteristics include: 1) the localization of Sox9EGFPLO to the intercalating crypt 
based columnar cell population, and 2) an active Notch1 pathway, which generally indicates suppression 
of secretory lineage differentiation (16). To further characterize the genetic signatures of Sox9EGFPLO 
cells, we assessed gene expression patterns for other putative intestinal stem cell biomarkers in 
Sox9EGFPLO FACSorted cells (Figure 3C). The data show enriched expression of the multipotent stem 
cell marker, Lrg5 (2), in Sox9EGFPLO cells as compared to the Sox9EGFPNEGATIVE population. Additionally, 
the mRNA for another putative intestinal stem cell marker, Musashi1 (32), was enriched in Sox9EGFPLO 
cells (Figure 3C).  
 
Sox9EGFPHI cells are mature/post-mitotic enteroendocrine cells 
 
 The decrease in Notch1-signaling in Sox9EGFPHI cells compared to Sox9EGFPLO cells (Figure 3B) 
led us to hypothesize that Sox9EGFPHI cells would be fate restricted to a secretory lineage. Because the 
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Notch1 pathway activation appeared to be suppressed in the Sox9EGFPHI cells, we predicted the lineage 
identity of this population would be either goblet or enteroendocrine cells. Paneth cell-lineage was ruled 
out because of the location of Sox9EGFPHI cells along the crypt-villus axis, a non-Paneth cell morphology, 
and the lack of co-localization with the Paneth cell marker, Lysozyme (Figure 1D). To identify the 
lineage of Sox9EGFPHI cells we stained the small intestine of Sox9EGFP mice with goblet marker, MUC2, 
and enteroendocrine markers, Substance-P and Chromogranin-A. No co-localization was observed with 
MUC2, indicating that Sox9EGFPHI cells are not of the Goblet lineage (data not shown). However, the 
results clearly demonstrate co-localization of Sox9EGFPHI cells with the enteroendocrine cell markers, 
Substance-P (61% colocalized) and Chromogranin-A (100% colocalized) (Figure 4A and 4B). 
To assess whether the Sox9EGFPHI cells in the crypts were immature cycling enteroendocrine 
precursors we stained small intestine from Sox9EGFP mice with Neurogenin3 (a biomarker of 
secretory/enteroendocrine progenitors) and the general proliferation marker, Ki67. We never detected 
colocalization of Ngn3 or Ki67 with Sox9EGFPHI in the adult small intestine (Figure 4C and 4D). These 
data, combined with the observation of Substance-P/Chromogranin-A expression in Sox9EGFPHI cells, 
indicate that Sox9EGFPHI cells are mature enteroendocrine cells. 
 
Increasing SOX9 levels in an intestinal progenitor cell line halts proliferation and elicits morphologic 
changes 
 
To define a functional role for increased levels of SOX9 enteroendocrine differentiation, we 
developed a gain-of-function assay in a non-transformed small intestine epithelial crypt cell line, IEC-
18. Spontaneous differentiation of the IEC-18 cells into enteroendocrine-like cells has been 
demonstrated indicating the multipotent capacity of these cells in culture (18). Based on the exclusive 
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expression of high SOX9 levels in non-cycling enteroendocrine cells in vivo, we predicted that 
increasing the levels of SOX9 beyond a particular threshold might fate specify these cells to an 
enteroendocrine-like fate and/or halt proliferation. To test this hypothesis we generated a lentiviral 
vector in which the constitutive CMV promoter drives Sox9 cDNA expression (Figure 5A). The 
recombinant lentiviral transduction results in stable integration of the Sox9 cDNA transgene into the 
IEC-18 genome and high levels of SOX9 expression (Figure 5B). After positive selection with 
puromycin, equal numbers of control- or SOX9-virus infected IEC-18 cells were plated and allowed to 
grow over a 10-day period. Control-virus infected cells proliferated normally, growing to a confluent 
monolayer, whereas SOX9-virus infected cells remained viable as single cells with no clonal 
populations appearing on the plate (Figure 5C). Additionally, Western-blot analysis demonstrated a 
decrease in Proliferating Cell Nuclear Antigen (PCNA), and also a decrease in c-MYC, a downstream 
target of ß-catenin signaling that supports proliferation (Figure 5D).  
A second striking observation was a distinct morphological change in SOX9-virus infected cells 
(Figure 5D & 5E). Between 8-10 days post infection, IEC-18 cells expressing high levels of SOX9 
transitioned from a typical IEC-18 epithelial cell morphology (small, uniform, flat cell body), to a 
morphology that resembled neuroendocrine morphology with a condensed cell body, dendritic/axonal-
like projections (Figure 5E), and/or possessing multiple vesicles (Figure 5F). These cells remained 
adherent and survived in culture until completion of the 10-day experiment. To determine if SOX9-
infected IEC-18 cells had differentiated into enteroendocrine cells, we immunostained these cells for 
mature enteroendocrine markers Chromogranin A and Substance P. Neither Chromogranin A nor 
Substance P antibodies demonstrated cross-reactivity with SOX9-virus infected cells (data not shown) 
indicating that SOX9-virus infected cells had not fully differentiated into mature enteroendocrine cells.  
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DISCUSSION: 
 
 The phenotypic effects of differential transcription factor levels have recently been the focus of 
several studies, which illustrate the importance of this biological property during the development of 
several tissues (15, 22, 33, 40, 42). In this study we utilized a transgenic reporter gene mouse to 
determine whether Sox9 was expressed at different levels in cells of the small intestinal epithelium. Our 
results indicate that there are two discrete steady-state levels of Sox9 mRNA and protein in the adult 
intestinal epithelium (now termed Sox9LOW and Sox9HIGH). Sox9LOW expressing cells exist in the lower 
crypt, whereas Sox9HIGH expressing cells are distributed primarily in the cell +4-6 position of the crypt 
and also sporadically throughout the villus epithelium. Our study shows that Sox9LOW-expressing cells 
are in part intercalated between the Paneth cells in the CBC population. Three-dimensional confocal 
crypt reconstruction showing Sox9LOW-expression in CBCs, combined with gene expression analysis 
showing enriched Lgr5 expression in Sox9LOW cells, demonstrates that Sox9LOW cells include the Lgr5+ 
multipotent stem cell population. Currently, an Lgr5 antibody that is able to detect mouse LGR5 does 
not exist thus precluding formal immunostaining analysis of the Sox9LOW population. Sox9HIGH cells in 
the crypt and villus are Chromogranin-A+ Ki67-, post-mitotic enteroendocrine cells. Gain-of-function 
studies in the IEC-18 intestinal crypt cell line indicate that high levels of SOX9 are involved in 
repressive modulation of proliferation in intestinal epithelial cells, and are perhaps influencing 
enteroendocrine cell fate specification.  
 Conditional deletion of Sox9 at E10.5 has been shown to ablate the Paneth cell population in the 
adult mouse (3, 26). An interesting observation from our study is that the Sox9EGFP transgene is never 
expressed in the Paneth cell population yet 50% of Paneth cells express SOX9 protein. Due to the rapid 
generation of the intestinal epithelium, a reasonable interpretation is that transcription from the Sox9 
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gene is terminated prior to Paneth cell differentiation and that SOX9 protein remains stabilized in 
‘younger’ Paneth cells. In ‘older’ Paneth cells SOX9 has degraded and results in a Lysozyme+/SOX9- 
population. The expression of SOX9 protein in only half of the Paneth cells may point to a unique role 
for the two populations in normal gut homeostasis, or implicate the requirement for SOX9 protein 
during the final stages of Paneth cell fate specification just prior to terminal differentiation and/or 
maturation at which time SOX9 is degraded.  
Our results clearly indicate that high levels of SOX9 are expressed in the enteroendocrine 
compartment of the small intestine epithelium. However, unlike the Paneth cell lineage, SOX9 
expression does not seem to be required for differentiation of enteroendocrine cells since there are no 
observable differences in the number of Chromogranin-A positive cells in an intestinal epithelium-
specific knockout for SOX9 (26). It might be predicted, because of the high levels of SOX9 specifically 
in enteroendocrine cells, that SOX9 normally influences the generation of the enteroendocrine cell 
lineage but its conditional loss at E10.5 is being compensated for by other SOX-factors. By contrast, no 
such compensation exists for Paneth cell differentiation as demonstrated by both Sox9-conditional 
knockout studies (3, 26).  
The literature is replete with examples of Sox-factor redundancy. For example, Sox1, Sox2 and 
Sox3 appear to functionally compensate for each other in neural stem/progenitor populations during 
development (12, 29, 35); Sox17 and Sox18 show redundant functions in post-natal angiogenesis (25); 
and Sox4 and Sox11 can compensate for Sox12 during early embryonic development (20). The mRNAs 
for Sox3, 4, 5, 7, 10, 17 and 18 have been detected in whole intestine preparations (5), therefore it is 
reasonable that another Sox-factor(s) may be functionally compensating for the loss of Sox9 during 
enteroendocrine cell fate decisions. An intriguing observation from our study that may support a role of 
SOX9 in differentiation is that when SOX9 was increased to high levels in IEC-18 cells, there was a 
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cellular phenotype that was characterized by a dramatic morphologic change in which cells acquired 
characteristics resembling a neuroendocrine morphology. We are cautious not to over-interpret these 
morphologic changes due to the absence of extrinsic influences on differentiation of IEC-18 cells in the 
in vitro context. In vivo studies are being conducted to address the role of SOX9 levels on differentiation 
of the intestinal epithelium. 
An alternative hypothesis for the role of Sox9 in the intestinal epithelium that was not tested in 
the conditional Sox9 knockout studies is that SOX9 may be required for proper expression of 
enteroendocrine specific genes. To date, no direct target genes for SOX9 have been identified in cells of 
the small intestine epithelium. Although there were no other gross phenotypic abnormalities observed in 
the Sox9 conditional knockout mice besides the loss of Paneth cells and crypt hyperproliferation, 
variations in enteroendocrine-specific SOX9 target genes might exist with a less overt phenotype. 
A generalized role for Sox9 in modulating proliferation through the Wnt/ß-catenin pathway is 
becoming clear (1, 3, 5, 26). Sox9 has been reported to be a downstream target of Wnt-signaling acting 
in a feedback loop to repress Wnt-signaling, thus keeping proliferation under tight regulatory control (1, 
3). The molecular mechanism responsible for this proliferation control has been established by over-
expressing SOX9 in human colon cancer lines (3). In these studies high levels of SOX9 were able to 
decrease transcription of ß-catenin target genes that positively regulate proliferation (i.e. c-myc, cyclin-
D1) and increase inhibitors of ß-catenin-Tcf proliferative activity (i.e. ICAT, TLE2-4). Both of these 
events would presumably result in decreased proliferative capacity, which was not formally tested. The 
data presented in our study are consistent with the findings in human colon cancer cell lines by showing 
that high levels of SOX9 expression in the non-transformed IEC-18 cell line decreases the ß-catenin 
target gene, c-MYC. Our study further demonstrates a functional decrease in proliferation and 
 22
expression of PCNA. Together, these data suggest that increasing SOX9 from low levels to high levels 
suppresses proliferation by decreasing ß-catenin signaling.  
Since Sox9 appears to be a Wnt-target gene, one question our data poses is whether Wnt-
signaling is responsible for the high Sox9 levels observed in non-cycling enteroendocrine cells. A recent 
study, however, demonstrates that even at the enteroendocrine precursor stage, Ngn3+ cells differentiate 
into enteroendocrine cells independently of Wnt-signaling (43) indicating that Sox9HIGH enteroendocrine 
cells would develop independently of Wnt-signaling. To reconcile these studies with our data, we 
propose a bi-modal role for Sox9 where low levels of Sox9 modulate proliferative capacity in the 
stem/progenitor cell compartment in a Wnt-dependent manner, while high levels of Sox9 in 
enteroendocrine precursors ablate proliferative capacity and influence terminal 
differentiation/maturation in a Wnt-independent manner (Figure 6). Based on our in vivo data 
demonstrating that all Sox9HIGH cells are mature and post-mitotic, combined with the in vitro data 
showing that high levels of SOX9 abrogates the proliferative capacity of IEC-18 cells, we support a 
model where Sox9 expression becomes uncoupled from Wnt-signaling at some point during 
enteroendocrine fate specification and acts to repress the proliferative capacity of cycling 
enteroendocrine precursors at the final stages of terminal differentiation. Our results indicate the 
uncoupling event would occur downstream of Ngn3 since co-localization of Ngn3 and Sox9HIGH is never 
observed in the Ngn3-fated progenitors. The crypt position for this ‘uncoupling event’ appears to occur 
on average at cell position +5 as there is a greater proportion of Sox9HIGH cells in this region of the 
crypts (Figure 2C). It has been previously reported that cell position +5 defines a niche for the 
differentiation of secretory lineages (4), thus the observation that Sox9HIGH cells in the crypt appear to 
primarily localize to cell position +4-6 (average +5) may point to an important source of extrinsic 
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factors at this crypt position that may be influencing high levels of Sox9 expression and the 
development/maturation of enteroendocrine cells.  
Subtle yet significant changes in the levels of steady-state gene expression have traditionally 
been difficult to assess at the cellular level because of the inability of existing technologies to accurately 
detect slight transcriptional variations. Transgenic reporter gene mice now enable high-resolution and 
real-time in vivo monitoring of gene transcription in normal and diseased states. Using this technology 
we have demonstrated that distinct levels of SOX9 in the intestinal epithelium are associated with both 
proliferative and post-mitotic cell types, and furthermore, that these variable SOX9 levels likely play an 
important role in both the control of proliferative capacity of stem/progenitor populations, and also the 
maturation of enteroendocrine cells. The Sox9EGFP mouse will also be a useful tool to investigate 
stem/progenitor populations during disease/injury and subsequent regeneration of the gut epithelium. 
Moreover, the ability to specifically FACS-isolate Sox9-expressing stem/progenitor populations for 
array-formatted gene expression studies will greatly enhance the ability to dissect important genetic 
pathways influencing normal gut homeostasis and diseased states involving the stem/progenitor cell 
compartment. 
 24
 ACKNOWLEDGEMENTS: 
 
We would like to acknowledge the UNC Neuroscience Confocal Imaging Facility (P30 
NS045892-04), the Center for GI Biology and Disease Imaging and Histology COREs 
(5P30DK034987), the UNC Chapel Hill Mutant Mouse Regional Resource Center, and the UNC Flow 
Cytometry CORE. We would also like to thank Priya Soni for technical support, and Drs. Kay Lund, 
Susan Henning, Michael Helmrath, Christopher Dekaney, Ajay Gulati, and Aaron Garrison for useful 
discussions. 
 
GRANTS: 
Funding was provided by the American Gastroenterological Association Research Scholar 
Award, the National Institutes of Health, 1-K01-DK080181-01, and the UNC-Chapel Hill Center for 
Gastrointestinal Biology and Disease, 5P30DK034987 (STM). 
 25
REFERENCES: 
 
1. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo 
MM, Nakamura T, Behringer RR, McCrea PD, and de Crombrugghe B. Interactions between Sox9 
and beta-catenin control chondrocyte differentiation. Genes & development 18: 1072-1087, 2004. 
2. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, 
Korving J, Begthel H, Peters PJ, and Clevers H. Identification of stem cells in small intestine and 
colon by marker gene Lgr5. Nature 449: 1003-1007, 2007. 
3. Bastide P, Darido C, Pannequin J, Kist R, Robine S, Marty-Double C, Bibeau F, Scherer 
G, Joubert D, Hollande F, Blache P, and Jay P. Sox9 regulates cell proliferation and is required for 
Paneth cell differentiation in the intestinal epithelium. The Journal of cell biology 178: 635-648, 2007. 
4. Bjerknes M and Cheng H. The stem-cell zone of the small intestinal epithelium. III. Evidence 
from columnar, enteroendocrine, and mucous cells in the adult mouse. The American journal of anatomy 
160: 77-91, 1981. 
5. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, Clevers H, and Jay 
P. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the 
CDX2 and MUC2 genes. The Journal of cell biology 166: 37-47, 2004. 
6. Bry L, Falk P, Huttner K, Ouellette A, Midtvedt T, and Gordon JI. Paneth cell 
differentiation in the developing intestine of normal and transgenic mice. Proceedings of the National 
Academy of Sciences of the United States of America 91: 10335-10339, 1994. 
7. Cheng H. Origin, differentiation and renewal of the four main epithelial cell types in the mouse 
small intestine. II. Mucous cells. The American journal of anatomy 141: 481-501, 1974. 
8. Cheng H. Origin, differentiation and renewal of the four main epithelial cell types in the mouse 
small intestine. IV. Paneth cells. The American journal of anatomy 141: 521-535, 1974. 
 26
9. Cheng H and Leblond CP. Origin, differentiation and renewal of the four main epithelial cell 
types in the mouse small intestine. I. Columnar cell. The American journal of anatomy 141: 461-479, 
1974. 
10. Cheng H and Leblond CP. Origin, differentiation and renewal of the four main epithelial cell 
types in the mouse small intestine. III. Entero-endocrine cells. The American journal of anatomy 141: 
503-519, 1974. 
11. Cheng H and Leblond CP. Origin, differentiation and renewal of the four main epithelial cell 
types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. The 
American journal of anatomy 141: 537-561, 1974. 
12. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji M, Norris D, Rastan S, 
Stevanovic M, Goodfellow PN, and Lovell-Badge R. A comparison of the properties of Sox-3 with 
Sry and two related genes, Sox-1 and Sox-2. Development (Cambridge, England) 122: 509-520, 1996. 
13. Dekaney CM, Rodriguez JM, Graul MC, and Henning SJ. Isolation and characterization of a 
putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 129: 1567-1580, 2005. 
14. Denny P, Swift S, Brand N, Dabhade N, Barton P, and Ashworth A. A conserved family of 
genes related to the testis determining gene, SRY. Nucleic Acids Res 20: 2887, 1992. 
15. Fantes J, Ragge NK, Lynch SA, McGill NI, Collin JR, Howard-Peebles PN, Hayward C, 
Vivian AJ, Williamson K, van Heyningen V, and FitzPatrick DR. Mutations in SOX2 cause 
anophthalmia. Nature genetics 33: 461-463, 2003. 
16. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, and Artavanis-Tsakonas S. Notch 
signals control the fate of immature progenitor cells in the intestine. Nature 435: 964-968, 2005. 
 27
17. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner 
A, Leblanc G, Hatten ME, and Heintz N. A gene expression atlas of the central nervous system based 
on bacterial artificial chromosomes. Nature 425: 917-925, 2003. 
18. Gordon PV, Paxton JB, and Fox NS. A methodology for distinguishing divergent cell fates 
within a common progenitor population: adenoma- and neuroendocrine-like cells are confounders of rat 
ileal epithelial cell (IEC-18) culture. BMC cell biology 6: 2, 2005. 
19. Graham V, Khudyakov J, Ellis P, and Pevny L. SOX2 functions to maintain neural progenitor 
identity. Neuron 39: 749-765, 2003. 
20. Hoser M, Potzner MR, Koch JM, Bosl MR, Wegner M, and Sock E. Sox12 deletion in the 
mouse reveals non-reciprocal redundancy with the related Sox4 and Sox11 transcription factors. 
Molecular and cellular biology, 2008. 
21. Kamachi Y, Uchikawa M, Tanouchi A, Sekido R, and Kondoh H. Pax6 and SOX2 form a co-
DNA-binding partner complex that regulates initiation of lens development. Genes & development 15: 
1272-1286, 2001. 
22. Kist R, Schrewe H, Balling R, and Scherer G. Conditional inactivation of Sox9: a mouse 
model for campomelic dysplasia. Genesis 32: 121-123, 2002. 
23. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, and Clevers H. 
Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature 
genetics 19: 379-383, 1998. 
24. Lobachevsky PN and Radford IR. Intestinal crypt properties fit a model that incorporates 
replicative ageing and deep and proximate stem cells. Cell Prolif 39: 379-402, 2006. 
 28
25. Matsui T, Kanai-Azuma M, Hara K, Matoba S, Hiramatsu R, Kawakami H, Kurohmaru 
M, Koopman P, and Kanai Y. Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. 
Journal of cell science 119: 3513-3526, 2006. 
26. Mori-Akiyama Y, van den Born M, van Es JH, Hamilton SR, Adams HP, Zhang J, Clevers 
H, and de Crombrugghe B. SOX9 is required for the differentiation of paneth cells in the intestinal 
epithelium. Gastroenterology 133: 539-546, 2007. 
27. Overton PM, Meadows LA, Urban J, and Russell S. Evidence for differential and redundant 
function of the Sox genes Dichaete and SoxN during CNS development in Drosophila. Development 
(Cambridge, England) 129: 4219-4228, 2002. 
28. Pevny LH and Lovell-Badge R. Sox genes find their feet. Curr Opin Genet Dev 7: 338-344, 
1997. 
29. Pevny LH, Sockanathan S, Placzek M, and Lovell-Badge R. A role for SOX1 in neural 
determination. Development (Cambridge, England) 125: 1967-1978, 1998. 
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic 
acids research 29: e45, 2001. 
31. Pinto D, Gregorieff A, Begthel H, and Clevers H. Canonical Wnt signals are essential for 
homeostasis of the intestinal epithelium. Genes & development 17: 1709-1713, 2003. 
32. Potten CS, Booth C, Tudor GL, Booth D, Brady G, Hurley P, Ashton G, Clarke R, 
Sakakibara S, and Okano H. Identification of a putative intestinal stem cell and early lineage marker; 
musashi-1. Differentiation 71: 28-41, 2003. 
33. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE, Taranova O, Pevny 
LH, and Hogan BL. Multiple dose-dependent roles for Sox2 in the patterning and differentiation of 
anterior foregut endoderm. Development (Cambridge, England) 134: 2521-2531, 2007. 
 29
34. Radford IR and Lobachevsky PN. An enteroendocrine cell-based model for a quiescent 
intestinal stem cell niche. Cell Prolif 39: 403-414, 2006. 
35. Rizzoti K, Brunelli S, Carmignac D, Thomas PQ, Robinson IC, and Lovell-Badge R. SOX3 
is required during the formation of the hypothalamo-pituitary axis. Nature genetics 36: 247-255, 2004. 
36. Sangiorgi E and Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nature 
genetics 40: 915-920, 2008. 
37. Scaffidi P and Bianchi ME. Spatially precise DNA bending is an essential activity of the sox2 
transcription factor. The Journal of biological chemistry 276: 47296-47302, 2001. 
38. Schonhoff SE, Giel-Moloney M, and Leiter AB. Minireview: Development and differentiation 
of gut endocrine cells. Endocrinology 145: 2639-2644, 2004. 
39. Stanger BZ, Datar R, Murtaugh LC, and Melton DA. Direct regulation of intestinal fate by 
Notch. Proceedings of the National Academy of Sciences of the United States of America 102: 12443-
12448, 2005. 
40. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR, and Pevny LH. 
SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes & development 20: 
1187-1202, 2006. 
41. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, 
Robine S, Winton DJ, Radtke F, and Clevers H. Notch/gamma-secretase inhibition turns proliferative 
cells in intestinal crypts and adenomas into goblet cells. Nature 435: 959-963, 2005. 
42. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, 
Keutel J, Huster E, Wolf U, Tommerup N, Schempp W, and Scherer G. Autosomal sex reversal and 
Campomelic Dysplasia are caused by mutations in and around the Sry-related gene SOX9. Cell 9: 1111-
1120, 1994. 
 30
43. Wang Y, Giel-Moloney M, Rindi G, and Leiter AB. Enteroendocrine precursors differentiate 
independently of Wnt and form serotonin expressing adenomas in response to active beta-catenin. 
Proceedings of the National Academy of Sciences of the United States of America 104: 11328-11333, 
2007. 
44. Weiss MA. Floppy SOX: mutual induced fit in hmg (high-mobility group) box-DNA 
recognition. Molecular endocrinology (Baltimore, Md 15: 353-362, 2001. 
45. Wissmuller S, Kosian T, Wolf M, Finzsch M, and Wegner M. The high-mobility-group 
domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic 
acids research 34: 1735-1744, 2006. 
46. Yang Q, Bermingham NA, Finegold MJ, and Zoghbi HY. Requirement of Math1 for 
secretory cell lineage commitment in the mouse intestine. Science 294: 2155-2158, 2001. 
 
 
 31
FIGURE LEGENDS: 
 
Figure 1 – Expression analysis of Sox9EGFP in the small intestine – (A) Sox9EGFP expression in jejunal 
crypts is localized to the base in intercalating CBCs and supra-Paneth cell locations. There are two 
distinct levels termed ‘HI’ and ‘LO’. (B) Sporadic Sox9EGFPHI-expressing cells are found throughout the 
villus epithelium. White arrows mark representative Sox9EGFPHI cells. Image at far right is a high 
magnification to demonstrate morphology. (C) Sox9EGFP expression does not colocalize with granulated 
Paneth cells. (D) Molecular confirmation that Sox9EGFP is not expressed in Paneth cells as marked by 
Lysozyme.  
 
Figure 2 – Validation of the Sox9EGFP transgene and whole-crypt analysis of SOX9 expression in 
Paneth cells – (A) SOX9 protein levels directly correlate with Sox9EGFP transgene expression levels. 
The nucleus of the Sox9EGFHI cell located higher up the crypt-villus is not in the focal plane of the 
confocal image and thus endogenous SOX9 is not observable. (B) Numbering scheme used to quantify 
the location of Sox9EGFPHI cells. Cell position 1 is located at the very base of the crypt. (C) Distribution 
of Sox9EGFPHI cells in the small intestine crypt. Variation is depicted as the standard error of the mean of 
three individuals counting one cell position difference either up or down the average cell position along 
crypt-villus axis. (D) Whole crypts were immunostained for Lysozyme and SOX9 and digitally 
reconstructed from 1 µm confocal slices. By assessing every Paneth cell in an intact jejunal crypt, two 
populations of Paneth cells can be define by either the presence or absence of SOX9. The ratio of 
SOX9+ to SOX9- Paneth cells was on average 1:1 (n=5 intact crypts, SOX9+ mean=2.6/crypt, 
S.E.M.=1.5; SOX9- mean=2.6/crypt S.E.M.=1.1). The images represent two different representative 
crypts (designated A and B). Each image represents a different optical slice on the Z-plane. Blue = 
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nuclei, Red = SOX9, Green = Lysozyme. RED arrows point to SOX9 positive Paneth cells. WHITE 
arrows point to SOX9 negative Paneth cells. 
 
Figure 3 – Gene expression analysis in isolated populations of Sox9EGFP-expressing cells – (A) FACS 
histogram demonstrates the three distinct populations of Sox9EGFP-expressing cells. Sox9EGFP cells were 
sorted based on EGFP intensities (either Negative, HI, or LO). (B) The FACS sort based on EGFP levels 
(and thus Sox9 mRNA levels) was validated as Sox9EGFPHI cells express 5-fold higher (S.E.M. = 1.2-
fold) Sox9 mRNA than Sox9EGFPLO cells. Sox9EGFPLO cells have 10.2-fold more Notch1 (S.E.M.=0.65-
fold) and 11.4-fold more Hes1 (S.E.M.=1.3-fold) mRNA compared to Sox9EGFPHI cells. Images to the 
right of the graph represent the cells post-sort. (C) Sox9EGFPLO cells are enriched in stem/progenitor cell 
marker genes. Sox9 (mean=6.7-fold higher, S.E.M.=2.3-fold), Lgr5 (mean=8.9-fold, S.E.M.=3.8-fold), 
Msi1 (mean=13.3, S.E.M.=3.6-fold); all p values <0.001.  
 
Figure 4 – Sox9EGFPHI cells are post-mitotic Enteroendocrine cells – Sox9EGFPHI cell lineage was 
identified by co-localization of EGFP with enteroendocrine-specific markers (A) Substance-P, (B) 
Chromogranin A. Post-mitotic status of Sox9EGFPHI cells was assessed by co-localization of EGFP with 
(C) Ki67 and (D) Ngn3. WHITE arrows depict representative cells. All images are 1 µm confocal 
optical slices. Note: (A) is EGFP fluorescence, and (B-C) is immunofluorescence staining for EGFP. 
Immunodetection of EGFP is required due to destruction of EGFP fluorescence by the antigen retrieval 
methods.  
 
Figure 5 – Phenotypic analysis of lentiviral-mediated increases in SOX9 levels – (A) Schematic of 
Lentiviral construct generated. The control lentiviral vector contains all the elements as the SOX9 
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lentiviral vector except the Sox9 cDNA. EGFP is translated from an Internal Ribosomal Entry Site 
(IRES) as a reporter gene to assess infection. The Puromycin gene is included to allow positive selection 
for viral integration into the genome. cDNA expression is driven by strong constitutive promoters (either 
CMV or PGK). (B) Validation of the SOX9 lentivirus. Forty-eight hours post-infection, IEC-18 cells 
were assessed for SOX9 by immunostaining (red), and EGFP autofluorescence (green). (C) IEC-18 cells 
were infected with equivalent titers of either control lentivirus or SOX9 lentivirus and selected with 
puromycin to deplete the cultures of untransduced cells. Equivalent numbers of cells were plated and 
allowed to grow for an additional 5 days. Images (left two panels) depict monolayers of IEC-18 cells 
that emerged in the control infected cells that express low endogenous levels of SOX9 (red). Right two 
panels depict cells infected with the SOX9 lentivirus. No proliferation (as detected by clonal 
populations) was observed in SOX9 lentivirus infected cells. Immunostaining for SOX9 (red) validates 
high expression of SOX9 in these cells. (D) Immunoblotting analysis of whole cell extracts made from 
control-virus (left lane) or SOX9-virus infected (right lane) IEC-18 cells. Blots were probed for c-MYC 
and PCNA using ß-actin expression as an internal control. (E) Morphologic phenotypes of SOX9 
lentivirus infected IEC-18 cells. Note neuroendocrine-like morphologies (axonal/dendritic processes and 
dense vesicle formations) were evident 6-8 days post-infection.  
 
Figure 6 – Model describing the relationship between Wnt and Sox9 in the adult intestinal epithelium 
– Multipotent CBCs universally express low-levels of Sox9 in a Wnt-dependent manner. Post-Ngn3 
lineage specification, instructive intrinsic and/or extrinsic signaling increases Sox9 expression to high 
levels in a Wnt-independent manner decreasing proliferative capacity and promoting terminal 
differentiation/maturation of enteroendocrine cells. 
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Figure S1 – Sox9EGFP does not co-localize with Lysozyme – Whole crypts were isolated from Sox9EGFP 
mice and stained for the Paneth cell marker Lysozyme (Red). Three-dimensional confocal imaging was 
conducted to assess staining throughout the entire crypt. Nuclei were stained with Draq5 (Blue). 
Sox9EGFP (Green). Each frame represents a 1 µm optical section. 
 
Figure S2 – SOX9-expression defines two populations of Paneth cells – Whole crypts were isolated 
from non-transgenic mice and stained for the Paneth cell marker Lysozyme (Green) and for SOX9 
(Red). Three-dimensional confocal imaging was conducted to assess staining throughout the entire 
crypt. Nuclei were stained with Draq5 (Blue). This 3-D reconstruction is representative of all crypts 
analyzed (n=5). Each frame represents a 1 µm optical section. 
 
 
 






